Global Intravascular Ultrasound Imaging Device Market Strategic Research Report

The global intravascular ultrasound (IVUS) imaging device market occupies a critical position within interventional cardiology, providing real-time, cross-sectional arterial visualization that angiography alone cannot deliver. Valued at approximately USD 1.08 billion in 2024, the market has become indispensable to catheterization laboratories worldwide, where IVUS guidance improves procedural precision during percutaneous coronary interventions (PCI), stent sizing, and plaque characterization. As cardiovascular disease remains the leading cause of mortality globally — accounting for an estimated 17.9 million deaths annually according to the World Health Organization — the demand for high-resolution, catheter-based imaging tools continues to intensify across both developed and emerging healthcare systems.

Three principal forces are accelerating market expansion through 2032. First, the rising global incidence of coronary artery disease and the corresponding growth in PCI procedure volumes directly expands the addressable opportunity for IVUS guidance systems; approximately 4.5 million PCI procedures are performed globally each year, and clinical evidence increasingly supports IVUS-guided PCI over angiography-alone approaches for improved major adverse cardiac event outcomes. Second, the migration from conventional single-element mechanical transducer catheters to solid-state phased-array and integrated IVUS-optical coherence tomography (OCT) co-registration platforms is elevating average selling prices and driving equipment refresh cycles at leading cardiac centers. Third, reimbursement expansion in key Asian markets — most notably Japan and South Korea, where IVUS guidance enjoys broad procedural reimbursement — continues to pull adoption across the region at rates exceeding the global average. A meaningful restraint, however, is the premium capital cost of IVUS console systems and the per-procedure cost of single-use imaging catheters, which limits penetration in cost-sensitive healthcare environments across Latin America, South Asia, and Sub-Saharan Africa.

This report delivers a comprehensive quantitative and strategic analysis of the global IVUS imaging device market across the 2025–2032 forecast horizon, anchored to a 2024 base year. Coverage spans market segmentation by device type and clinical application, regional and country-level forecasting, competitive profiling of ten major commercial participants, and structured frameworks including Porter's Five Forces, PESTLE, and SWOT analysis. The report is principally designed for corporate strategy teams evaluating portfolio expansion, investment analysts conducting sector due diligence, M&A advisors assessing acquisition targets, and procurement managers benchmarking capital equipment decisions.